@FiercePharma: Scotland rejects Avastin for ovarian cancer. Roche says the Scots need a cancer-drugs fund like England's. Report | Follow @FiercePharma
> European regulators said they will decide next year whether to fine Denmark's Lundbeck and France's Servier for antitrust violations related to generic versions of their drugs. Report
> Bayer won European approval for its new contraceptive combination drug Flexyess, which comprises drospirenone and ethinylestradiol. Report
> Questcor ($QCOR) said prescriptions for its Acthar product amounted to about 520 in September, compared with about 630 in August. Report
> India's Dr Reddy's expanded its manufacturing operations in the U.K. to increase production of active pharmaceutical ingredients for drug development. Report
> India's Piramal Healthcare is eyeing acquisitions in the U.S. and Europe to expand its contract research and manufacturing operations. Report
> Expired drugs were found to retain their potency in a new study, prompting calls to reconsider expiration-date policies in an attempt to save money on drugs. Report
> Baxter International ($BAX) says it expects earnings to increase by 7% to 9% over the next 5 years as sales grow by 5% annually. Report
@FierceMedDev: AngioDynamics has agreed to purchase Vortex Medical for $55M. News | Follow @FierceMedDev
@MarkHFierce: Stem cells derived from skin to be tested in humans as eye disease treatment--via Bloomberg. Article | Follow @MarkHFierce
@DamianFierce: Boston Scientific will pay up to $265M for Rhythmia Medical. News | Follow @DamianFierce
> St. Jude may lose defibrillator lead partner. Story
> Accutron recalls flowmeters over gas risk. Item
Biotech News
@FierceBiotech: Fight against 'unwarranted' drug patents goes online. FierceBiotechIT article | Follow @FierceBiotech
@JohnCFierce: Interesting. Twitter conclusion: Solanezumab a complete bust. But on BMBG, Reuters etc., it's an intriguing "win" for patients. Disconnect. | Follow @JohnCFierce
@RyanMFierce: Magic Johnson is using his celebrity to bring attention to OraSure's at-home HIV test. A good use of his celebrity, I think. | Follow @RyanMFierce
> Merck to shutter longtime NJ HQ in corporate reshuffle. News
> Billionaire Kirk orchestrates $45M cell therapy tie-up in biotech deal spree. Story
> Merck taps startup from Down Under for vaccine patch. Article
> Eli Lilly surges on conflicting data for Alzheimer's drug solanezumab. Report
Pharma Manufacturing News
> Compounder tied to meningitis deaths sold large quantities. News
> Sanofi Pasteur reports more issues with vaccine quality. Story
> Mold found in Hospira dextrose solution. Report
Biotech Research News
> Japanese scientists weld stem cells to create eggs and then baby mice. More
> RXi gains SBIR grant to pursue RNAi eye cancer drug. News
> Athersys stem cell therapy displays power as MS treatment. Article
> Inovio preclinical results prove skin delivery potency for DNA vaccines. Story
And Finally... Novartis ($NVS) launched a YouTube talk show about advanced breast cancer. Report